⚠️
Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Elevated antipsychotic prescribing (65+)
Risk indicators are statistical patterns, not allegations. Learn more
8,672
Total Claims
$1.7M
Drug Cost
999
Beneficiaries
$1,716
Cost/Patient
Risk Score Breakdown 6/100
Low (0)Moderate (15)Elevated (30)High (50+)
Elderly antipsychotic prescribing+5
Score components are additive. Read full methodology
Peer Comparison vs. 8,961 Nephrology providers
+34%
Cost per patient vs peers
$1,716 vs $1,283 avg
+78%
Brand preference vs peers
16.0% vs 9.0% avg
Brand vs Generic
84% generic
Brand: 1,377 claims · $1.4M
Generic: 7,252 claims · $350K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dapagliflozin Propanediol | 451 | $395K |
| Voclosporin | 12 | $151K |
| Finerenone | 128 | $146K |
| Patiromer Calcium Sorbitex | 80 | $99K |
| Sitagliptin Phosphate | 55 | $88K |
| Cinacalcet Hcl | 92 | $79K |
| Semaglutide | 32 | $58K |
| Apixaban | 38 | $44K |
| Epoetin Alfa | 38 | $39K |
| Sacubitril/Valsartan | 30 | $36K |
| Ferric Citrate | 16 | $35K |
| Sevelamer Carbonate | 52 | $28K |
| Empagliflozin | 23 | $25K |
| Sodium Zirconium Cyclosilicate | 23 | $21K |
| Semaglutide | 20 | $20K |
Prescribing Profile
Patient Profile
78
Avg Age
49%
Female
3.09
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About